Multicenter study of combination therapy using mizoribine, cyclosporin, basiliximab and steroids in kidney transplantation.

Trial Profile

Multicenter study of combination therapy using mizoribine, cyclosporin, basiliximab and steroids in kidney transplantation.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Apr 2016

At a glance

  • Drugs Mizoribine (Primary) ; Basiliximab; Ciclosporin; Corticosteroids; Mycophenolate mofetil
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2012 Planned End Date (1 May 2013) added as reported by University Hospital Medical Information Network - Japan.
    • 01 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 01 Jul 2009 Planned number of patients (70) identified as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top